by AdoloreJTC24 | Jul 5, 2023 | Press Releases
Live moderated video webcast on Tuesday, July 11th at 4:00 PM ETDELRAY BEACH, FL / July 5, 2023 / Adolore Biotherapeutics (“Adolore” or the “Company”), a biotechnology company focused on developing breakthrough opioid-free gene therapy...
by AdoloreJTC24 | Jun 27, 2023 | Press Releases
Company developing next generation, disease-modifying, non-opioid analgesic gene therapies for the treatment of chronic painDELRAY BEACH, FL / June 27, 2023 / Adolore Biotherapeutics, Inc. (“Adolore” or the “Company”) a biotechnology company...
by AdoloreJTC24 | May 23, 2023 | Press Releases
Company developing next generation, disease-modifying, non-opioid analgesic gene therapies for the treatment of chronic painDELRAY BEACH, FL / May 23, 2023 / Adolore Biotherapeutics, Inc. (“Adolore” or the “Company”) a biotechnology company...
by AdoloreJTC24 | May 16, 2023 | Press Releases
Company developing next generation, disease-modifying, non-opioid analgesic gene therapies for the treatment of chronic painDELRAY BEACH, FL / May 16, 2023 / Adolore Biotherapeutics, Inc. (“Adolore” or the “Company”) a biotechnology company...
by AdoloreJTC24 | Feb 22, 2023 | Press Releases
DELRAY BEACH, FL / February 22, 2023 / Adolore Biotherapeutics, Inc. (“Adolore” or the “Company”) a biotechnology company focused on developing breakthrough opioid-free pain relieving (analgesic) treatments for pain, today announced that Dr....
by AdoloreJTC24 | Jan 18, 2023 | Press Releases
Live video webcast presentation on Thursday, January 19th at 10:00 AM ETDELRAY BEACH, FL / January 18, 2023 / Adolore Biotherapeutics, Inc. (“Adolore” or the “Company”) a biotechnology company focused on developing breakthrough opioid-free pain...